Novo Nordisk’s Thomsen Says IDegLira Data ‘Unprecedented’BloombergNovo Nordisk A/S (NOVOB)’s combination of a new insulin with its established Victoza therapy lowered blood-sugar to unprecedented levels and should be an important diabetes treatment once approved, Chief Science Officer Mads Krogsgaard Thomsen …Lilly’s Once-Weekly Dulaglutide Shows Similar Reductions in Average Blood …Wall Street JournalLilly bets its diabetes drug dulaglutide can dominate a crowded classFierceBiotechNew Phase 3 Study Shows Efficacy and Safety of Victoza(R) (Liraglutide [rDNA …MarketWatchGlobalPostall 21 news articles …Read Full Story
Novo Nordisk's Thomsen Says IDegLira Data 'Unprecedented' - Bloomberg
Real Estate of Cebu
